Table III.
Summary of intravenous antihypertensive medications.
Patients with RD | Patients without RD | Total | |
---|---|---|---|
Total sample size (safety population) | 24 | 102 | 126 |
Received ≤ 1 IV antihypertensive(s) with CLV | 2 (8.3) | 9 (8.8) | 11 (8.7) |
Received ≤ 1 IV antihypertensive(s) without CLV | 1 (4.2) | 7 (6.9) | 8 (6.3) |
Received monotherapy of CLV | 21 (87.5) | 86 (84.3) | 107 (84.9) |